Instil Bio, Inc.
TIL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $5,987 | $0 |
| Gross Profit | $0 | $0 | -$5,987 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $11,838 | $39,604 | $141,056 | $107,251 |
| G&A Expenses | $44,210 | $47,553 | $62,235 | $48,309 |
| SG&A Expenses | $44,210 | $47,553 | $62,235 | $51,309 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $3,000 |
| Other Operating Expenses | $17,493 | $72,012 | -$3,108 | -$3,000 |
| Operating Expenses | $73,541 | $159,169 | $200,183 | $155,560 |
| Operating Income | -$73,541 | -$159,169 | -$206,170 | -$155,560 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$594 | $3,082 | -$19,080 | -$1,195 |
| Pre-Tax Income | -$74,135 | -$156,087 | -$225,250 | -$156,755 |
| Tax Expense | $0 | $0 | -$2,073 | $39 |
| Net Income | -$74,135 | -$156,087 | -$223,177 | -$156,794 |
| % Margin | – | – | – | – |
| EPS | -11.39 | -24 | -34.46 | -29.6 |
| % Growth | 52.5% | 30.4% | -16.4% | – |
| EPS Diluted | -11.39 | -24 | -34.46 | -29.6 |
| Weighted Avg Shares Out | 6,510 | 6,504 | 6,476 | 5,300 |
| Weighted Avg Shares Out Dil | 6,510 | 6,504 | 6,476 | 5,300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,987 | $8,866 | $3,655 | $80 |
| Interest Expense | $8,992 | $5,209 | $1,883 | $0 |
| Depreciation & Amortization | $3,610 | $4,756 | $5,987 | $2,752 |
| EBITDA | -$62,528 | -$147,117 | -$217,380 | -$152,514 |
| % Margin | – | – | – | – |